The traditional pharmaceutical order, once anchored in Western centres, has fundamentally shifted. We now inhabit a bipolar industry landscape dominated by the United States and China. This transformation carries significant implications for patients, investors, and policymakers worldwide. Chinese Pharmaceutical Innovation Drives Global Research Boom China has rapidly closed the gap in medical research. In several key areas, it has now…
Tag: Biotech
-
FDA Unpredictable: Moderna Challenges the Agency
Moderna has launched a rare public attack on the US Food and Drug Administration, warning that an “unpredictable” regulator could weaken America’s lead in drug innovation. During the call, company leaders specifically argued that the FDA’s unpredictable decision-making undermines industry momentum. The comments came during the company’s Friday analyst call. This was just days after the FDA declined to accept…